ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Sjogren’s syndrome"

  • Abstract Number: 3202 • 2015 ACR/ARHP Annual Meeting

    Functional Anti-Muscarinic Receptor-3 Monoclonal Antibodies Derived from Salivary Gland in Patients of Sjögren’s Syndrome

    Syed M.S. Quadri1,2, Kristi A. Koelsch3, Valerie Harris4, Biji T Kurien5 and R. Hal Scofield6, 1Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Okalahoma City, OK, 4University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Arthritis and Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: Sjögren's syndrome (SS) is a chronic autoimmune inflammatory disease characterized by bilateral hypofunction of lacrimal and salivary glands leading to keratoconjuctivitis and xerostomia. The…
  • Abstract Number: 628 • 2015 ACR/ARHP Annual Meeting

    Poor Prognosis of Patients with Primary Sjögren Syndrome Who Fulfilled at Diagnosis the Classification Criteria for Concomitant Cryoglobulinemic Vasculitis

    Soledad Retamozo1,2, Hoda Gheitasi3, Luca Quartuccio4, Belchin Kostov5, Laura Corazza4, Albert Bové3, Antoni Sisó-Almirall5, Myriam Gandía3, Manuel Ramos-Casals1, Salvatore De Vita6 and Pilar Brito-Zerón1, 1Department of Autoimmune Diseases, CELLEX-IDIBAPS, Hospital Clínic, Barcelona, Barcelona, Spain, 2Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, 3Department of Autoimmune Diseases, IDIBAPS, Hospital Clínic, Barcelona, Spain, 4S. Maria della Misericordia, University of Udine, Italy, Udine, Italy, 5Primary Care Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Primary Care Centre Les Corts, CAPSBE, Barcelona, Spain, 6Santa Maria della Misericordia Hospital, University of Udine, Udine, Italy

    Background/Purpose: To evaluate the fulfilment of classification criteria for cryoglobulinemic vasculitis (CV) at diagnosis in a large cohort of patients with primary Sjögren syndrome (SS)…
  • Abstract Number: 1052 • 2015 ACR/ARHP Annual Meeting

    Identification of Novel Sjogren’s Syndrome Risk Loci in the Regions of TNFAIP3 and PRDM1

    Christopher J. Lessard1,2, He Li1,2, John Ice2, Indra Adrianto3, Astrid Rasmussen2, Kiely Grundahl4, Jennifer A. Kelly5, Corinne Miceli6, Simon Bowman7, Susan Lester8, Johan G. Brun9,10, Lasse G. Goransson11, Erna Harboe11, Joel M. Guthridge2, Kenneth M. Kaufman12,13, Per Eriksson14, Maija-Leena Eloranta15, Marika Kvarnström16, Deborah S. Cunninghame-Graham17, A. Darise Farris2, Michael T. Brennan18, James Chodosh19, Raj Gopalakrishnan20, Andrew J.W. Huang21, Pamela Hughes22, David M. Lewis23, Lida Radfar24, Michael D. Rohrer25, Donald U. Stone26, Timothy J. Vyse17, Patrick M. Gaffney2, Judith A. James1,5,27, John B. Harley12,28, Roald Omdal11, Marie Wahren-Herlenius16, Gabor G. Illei29, Torsten Witte30, Roland Jonsson10,31, Maureen Rischmueller32,33, Lars Rönnblom34, Xavier Mariette35, Juan-Manuel Anaya36, Wan-Fai Ng37, Gunnel Nordmark34, Courtney G. Montgomery2, Nelson L. Rhodus38, Barbara M. Segal39, R. Hal Scofield2,27,40 and Kathy L. Sivils1,2, 1Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma CIty, OK, 5Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 6Rheumatology, PARIS, France, 7Rheumatology Dept, University Hospital Birmingham, Birmingham, United Kingdom, 8Queen Elizabeth Hospital, Adelaide, Australia, 9Institute of Internal Medicine, University of Bergen, Bergen, Norway, 10Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, 11Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, 12US Department of Veterans Affairs Medical Center, Cincinnati, OH, 13Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 14Department of Clinical and Experimental Medicine, Rheumatology/AIR, Linköping University, Linköping, Sweden, Linköping, Sweden, 15Department of Medical Sciences, SciLife Lab, Rheumatology, Uppsala University, Uppsala, Sweden, Uppsala, Sweden, 16Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 17Department of Medical and Molecular Genetics, King's College London, London, United Kingdom, 18Department of Oral Medicine, Carolinas Medical Center, Charlotte, NC, 19Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 20Diagnostic and Biological Sciences, Division of Oral Pathology, University of Minnesota, Minneapolis, MN, 21Department of Ophthalmology and Visual Sciences, Washington University, St Louis, MO, 22Division of Oral and Maxillofacial Surgery, Department of Developmental and Surgical Science, University of Minnesota School of Dentistry, Minneapolis, MN, 23College of Dentistry, Department of Oral and Maxillofacial Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 24Oral Diagnosis and Radiology Department, University of Oklahoma Health Sciences Center College of Dentistry, Oklahoma City, OK, 25Hard Tissue Research Laboratory, University of Minnesota School of Dentistry, Minneapolis, MN, 26Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 27Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 28Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 29National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, 30Hannover Medical School, Hanover, Germany, 31Broegelmann Research Laboratory, The Gade Institute, University of Bergen, Bergen, Norway, 32University of Adelaide, Adelaide, Australia, 33Department of Rheumatology, The Queen Elizabeth Hospital, Adelaide, Australia, 34Rheumatology, Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden, 35AP-HP, Hopitaux Universitaires Paris-Sud, Université Paris-Sud, Paris, France, 36Center for Autoimmune Diseases Research (CREA), Universidad del Rosario, Bogotá, Colombia, 37Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 38Department of Oral Surgery, University of Minnesota School of Dentistry, Minneapolis, MN, 39Division of Rheumatology, University of Minnesota Medical School, Minneapolis, MN, 40US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a complex autoimmune disease with both environmental and genetic factors playing important roles in its pathophysiology. The goal of this…
  • Abstract Number: 2784 • 2015 ACR/ARHP Annual Meeting

    Faecal Levels of Calprotectin Are Increased in Patients with Primary Sjögren’s Syndrome and Correlates with Disease Activity

    Thomas Mandl1, Bodil Ohlsson2 and Kristofer Andreasson3, 1Dept of Rheumatology, Skåne University Hospital Malmö, Lund University, Malmo, Sweden, 2Dept of Internal Medicine, Skane University Hospital Malmo, Lund University, Sweden, Malmo, Sweden, 3Dept of Rheumatology, Skane University Hospital Lund, Lund University, Sweden, Lund, Sweden

    Background/Purpose: FC is a validated biomarker differentiating inflammatory bowel disease from irritable bowel syndrome. We have evaluated faecal levels of calprotectin (FC) in patients with…
  • Abstract Number: 3204 • 2015 ACR/ARHP Annual Meeting

    Hypoechoic Lesions on Parotid Gland Ultrasound Are a Surrogate Marker of Focal Lymphocytic Sialadenitis on Minor Salivary Gland Biopsy in Sjögren’s Syndrome

    Thomas Grader-Beck1, Joel Fradin2, Jean Kim3, Esen Akpek4, Brendan Antiochos5, Julius Birnbaum6 and Alan N. Baer7, 1Medicine Div of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 3Otolaryngology, Head & Neck Surgery, Johns Hopkins University, Baltimore, MD, 4Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, 5Medicine-Division of Rheumatology, Johns Hopkins University, Baltimore, MD, 6Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, 7Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: To determine whether hypoechoic lesions on parotid gland ultrasound can serve as a surrogate marker for a focus score ≥1 on minor salivary gland…
  • Abstract Number: 629 • 2015 ACR/ARHP Annual Meeting

    Salivary Gland Ultrasonography As an Useful Tool to Distinguish Patients with Sjögren’s Syndrome at Risk for Non-Hodgkin’s Lymphoma Development

    Chiara Baldini1, Nicoletta Luciano1, Francesco Ferro1, Chiara Stagnaro1, Daniela Martini1, Marta Mosca2 and Stefano Bombardieri1, 1Rheumatology Unit, University of Pisa, Italy, Pisa, Italy, 2University of Pisa, Pisa, Italy

    Background/Purpose: Salivary gland ultrasonography has been proposed as a promising novel tool for the diagnosis of primary Sjögren’s syndrome (SS).  An increasing number of studies…
  • Abstract Number: 1053 • 2015 ACR/ARHP Annual Meeting

    Phosphatidylinositol-3-Kinase Delta Pathway a Novel Therapeutic Target for Sjogren’s Syndrome

    Saba Nayar1, Joana Campos1, Christopher Buckley1, Rodger Allen2, W.A. Fahy2, Andrew Payne2 and Francesca Barone1, 1University of Birmingham, Rheumatology Research Group, Birmingham, United Kingdom, 2UCB Pharma, Slough, United Kingdom

    Background/Purpose: Sjögren’s syndrome (SS) is a chronic autoimmune disease characterized by B cell hyper-activation and exocrine gland infiltration that results in loss of glandular function,…
  • Abstract Number: 2785 • 2015 ACR/ARHP Annual Meeting

    Association of Anti-Glutamate Receptor Subunit NR2 Antibody and Psychiatric Disorder in Patients with Primary Sjögren Syndrome

    Yoshiyuki Arinuma1,2, Yuko Sakuma3, Eisuke Ogawa2, Tatsuhiko Wada4, Tatsuo Nagai2, Sumiaki Tanaka2 and Shunsei Hirohata2, 1Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, Manhasset, NY, 2Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Kanagawa, Japan, 3Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Kanagawa, Japan, 4Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan

    Background/Purpose: Sjögren syndrome (SjS) is one of the autoimmune disease characterized by the production of autoantibodies. Patients with SjS frequently observe psychiatric manifestation such as…
  • Abstract Number: 3205 • 2015 ACR/ARHP Annual Meeting

    Treatment with Abatacept or Rituximab Targets T Follicular Helper Cells in Patients with Primary Sjogren s Syndrome

    Gwenny M. Verstappen1, Petra M. Meiners2, Odilia B.J. Corneth3, Rudi W. Hendriks3, Arjan Vissink4, Frans G.M. Kroese5 and Hendrika Bootsma5, 1Rheumatology & Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 2Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 3Pulmonary Medicine, Erasmus MC, Rotterdam, Netherlands, 4Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 5Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

    Background/Purpose: T cell-dependent B cell hyperactivity is a characteristic pathogenetic feature of primary Sjögren’s syndrome (pSS). This is illustrated by the finding that treatment of…
  • Abstract Number: 631 • 2015 ACR/ARHP Annual Meeting

    Usefulness of the Minimally-Invasive Minor Salivary Gland Biopsy in Patients Presenting with Sicca Syndrome: Prospective Evaluation of 200 Patients

    Soledad Retamozo1, Pilar Brito-Zerón1, Albert Bové2, Hoda Gheitasi2, Courtney Grant3, Daphne Superville4, Belchin Kostov5, Antoni Sisó-Almirall5, Llucia Alós6 and Manuel Ramos-Casals1, 1Department of Autoimmune Diseases, CELLEX-IDIBAPS, Hospital Clínic, Barcelona, Barcelona, Spain, 2Department of Autoimmune Diseases, IDIBAPS, Hospital Clínic, Barcelona, Spain, 3University of Glasgow, Glasgow, United Kingdom, 4Massachusetts Institute of Technology (MIT), Cambridge, MA, 5Primary Care Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Primary Care Centre Les Corts, CAPSBE, Barcelona, Spain, 6Department of Pathology, Hospital Clínic, Barcelona, Spain

    Background/Purpose: Sicca syndrome is a clinical presentation that is common for several systemic diseases that may infiltrate the exocrine glands. The most frequent disease is…
  • Abstract Number: 1055 • 2015 ACR/ARHP Annual Meeting

    Expansions of Salivary Gland CD4+ T Cells from Sjögren’s Syndrome Patients: Single-Cell Repertoire Analysis and Correlation with Clinical Measures of Disease

    Michelle L. Joachims1, Kerry M. Leehan2,3, Christina M. Lawrence3, Astrid Rasmussen3, Lida Radfar4, David M. Lewis5, Glen D Houston6, Kiely Grundahl3, Donald U. Stone7,8, Kimberly Hefner9, R. Hal Scofield2,10,11, Kathy L. Sivils2,3, Linda F. Thompson12 and A. Darise Farris1,2, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Oral Diagnosis and Radiology Department, University of Oklahoma Health Sciences Center College of Dentistry, Oklahoma City, OK, 5College of Dentistry, Department of Oral and Maxillofacial Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 6Heartland Pathology, Oklahoma City, OK, 7Department of Ophthalmology, Johns Hopkins University, Baltimore, MD, 8King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, 9Hefner Eye Care and Optical Center, Oklahoma City, OK, 10College of Medicine, Section of Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 11Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 12Immunobiology and Cancer Program, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose:   CD4+ T cells predominate in salivary gland (SG) focal lymphocytic infiltrates in primary Sjögren’s syndrome (pSS).  However, their antigen specificity, degree of clonal…
  • Abstract Number: 2787 • 2015 ACR/ARHP Annual Meeting

    Expression of Interferons Lambda in Salivary Glands of Patients with Sjögren’s Syndrome

    Eirini Apostolou1, Efstathia K. Kapsogeorgou1, Orsia D. Konsta1, Maria Ioanna Saridaki2, Evangelos Andreakos2 and Athanasios G. Tzioufas1, 1Pathophysiology, Faculty of Medicine, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece, 2Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece

    Background/Purpose: Type I and II interferons (IFNs) have been implicated in the pathophysiology of Sjögren’s Syndrome (SS). Recently a new family of IFNs, namely type…
  • Abstract Number: 632 • 2015 ACR/ARHP Annual Meeting

    Isolated Atrioventricular Block of Unknown Origin in the Adult and Autoimmunity: Diagnostic and Therapeutic Considerations Exemplified By Three Anti-Ro/SSA-Associated Cases

    Antonio Brucato1, Pietro Enea Lazzerini2, Pier Leopoldo Capecchi3, Anna Valenti4, Lucia Baldi5, Maria Romana Bacarelli3, Claudia Nucci5, Valentina Moscadelli3, Gabriella Morozzi3, Mohamed Butjdir6,7,8 and Franco Laghi Pasini3, 1Internal Medicine, Ospedale Papa Giovanni XXIII Bergamo, Bergamo, Italy, 2Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy, 3Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy, 4Internal Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy, 5Cardiology, University of Siena, Siena, Italy, 6Medicine, Cell Biology and Pharmacology, State University of New York at Downstate Medical Center, New York, NY, 7NYU School of Medicine, New York, NY, 8Research Department, VA New York Harbor Healthcare System, New York, NY

    Background/Purpose:  Circulating anti-Ro/SSA antibodies may rarely affect the adult conduction-system. A direct autoantibody-mediated electrophysiological inhibition of cardiomyocyte calcium-channels (acquired form) or an ante-natal subclinical injury…
  • Abstract Number: 1056 • 2015 ACR/ARHP Annual Meeting

    Aquaporin Gene Therapy Corrects Bone Morphogenetic Protein 6 Associated Exocrine Gland Dysfunction in Mouse Model of Sjögren’s Syndrome

    Hongen Yin1, Zhennan Lai2, Javier Cabrera-Perez3, Patricia Glenton4, Ankur Patel5, William Swaim5, Changyu Zheng5, Maria Guimaro5, Sandra Afione6, Cuong Nguyen5, Fred Nyberg7 and John A. Chiorini2, 1NIDCR, NIH, Bethesda, MD, 2Mptb, NIH/NIDCR, Bethesda, MD, 3Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Bethesda, MD, 4Department of Pathology and Infectious Diseases, University of Florida, Gaineville, FL, 5Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, 6National Institute of Dental and Craniofacial Research, Bethesda, MD, 7Department of Pharmaceutical Bioscience, Division of Biological Research on Drug Dependence, Uppsala University, Uppsala, MD, Sweden

    Background/Purpose: Loss of secretory epithelial function is a hallmark of primary Sjögren’s syndrome (pSS). Previously we reported that bone morphogenetic protein 6 (BMP-6) inhibits cell volume…
  • Abstract Number: 2794 • 2015 ACR/ARHP Annual Meeting

    A New Scoring System for Ultrasonographic Evaluation of Salivary Gland in Sjogren: Multireader Reliability

    Sandrine Jousse-Joulin1, Malin V. Jonsson2, Nicoletta Luciano3, Elke Theander4, Vera Milic5, Alojzija Hocevar6, Jacqueline Brown7, Andrew Carr8, Divi Cornec9, Marina Carotti10, Benjamin A. Fisher11, Joel Fradin12, John Rout13, Alain Saraux14, Alja Stel15, Arjan Vissink16, Simon Bowman17, Alan N. Baer18, Matija Tomšič6, Wan-Fai Ng19, Chiara Baldini3 and Valerie Devauchelle20, 1Rheumatology, CHu La cavle Blanche, Brest, France, 2Department of Clinical Dentistry, Section for Oral and Maxillofacial Radiology,, University of Bergen, Bergen, Norway, 3Rheumatology Unit, University of Pisa, Italy, Pisa, Italy, 4Skåne University Hospital Malmö, Lund University, Malmo, Sweden, 5rheumatology, belgrade university, belgrade, Serbia, 6Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 7dental division, Tower Wing Guy's hospital, london, United Kingdom, 8departement of radiology, University of Newcastle, New castle, United Kingdom, 9Department of rheumatology, Brest Occidentale University, Brest, France, 10Istituto di Radiologia, Ospedali Riuniti di Ancona, Ancona, Italy, 11Kennedy Institute of Rheumatology, Imperial College London, London, United Kingdom, 12Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 13Birmingham Dental Hospital, Birmingham, United Kingdom, 14Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, 15Hanzeplein 1, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 16Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 17Rheumatology Dept, University Hospital Birmingham, Birmingham, United Kingdom, 18Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 19Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, 20Service de Rhumatologie, CHU Brest, Brest, France

    Background/Purpose: A new consensual scoring system for Ultrasonography (US) of the salivary gland in pSS is required and endorsed by an international group of experts…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 26
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology